Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Balis

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Neuro-Oncology|August 8, 2002
Mixing during intravertebral arterial infusions in an in vitro modelRobert J Lutz, Kathy Warren, Frank Balis, et al.
Journal of Adolescent and Young Adult Oncology|March 27, 2014
A Qualitative Study of Phase III Cancer Clinical Trial Enrollment Decision-Making: Perspectives from Adolescents, Young Adults, Caregivers, and ProvidersLamia P Barakat, Lisa A Schwartz, Anne Reilly, et al.
Pediatric Blood & Cancer|August 28, 2016
Pencil beam scanning proton therapy for treatment of the retroperitoneum after nephrectomy for Wilms tumor: A dosimetric comparison studyJennifer Vogel, Haibo Lin, Stefan Both, et al.
The Oncologist|February 16, 2018
Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and CisplatinElizabeth Fox, Kristin Levin, Yan Zhu, et al.
Pediatric Blood & Cancer|September 24, 2024
Atypical presentations of RECQL4-related syndromesLiron D Grossman, Sarah Baldino, Kristin Zelley, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcomaElizabeth Fox, Christine Busch, Alexander DeBernardo, et al.
International Journal of Pediatric Endocrinology|May 15, 2015
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapyMaya Lodish, Alexandra Gkourogianni, Ethan Bornstein, et al.
Blood Advances|July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairmentCatherine Lai, Diane E Cole, Seth M Steinberg, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Mutation Research|June 2, 2005
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administrationV Koneti Rao, Turid Knutsen, Thomas Ried, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Neuro-Oncology|August 8, 2002
Mixing during intravertebral arterial infusions in an in vitro modelRobert J Lutz, Kathy Warren, Frank Balis, et al.
Journal of Adolescent and Young Adult Oncology|March 27, 2014
A Qualitative Study of Phase III Cancer Clinical Trial Enrollment Decision-Making: Perspectives from Adolescents, Young Adults, Caregivers, and ProvidersLamia P Barakat, Lisa A Schwartz, Anne Reilly, et al.
Pediatric Blood & Cancer|August 28, 2016
Pencil beam scanning proton therapy for treatment of the retroperitoneum after nephrectomy for Wilms tumor: A dosimetric comparison studyJennifer Vogel, Haibo Lin, Stefan Both, et al.
The Oncologist|February 16, 2018
Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and CisplatinElizabeth Fox, Kristin Levin, Yan Zhu, et al.
Pediatric Blood & Cancer|September 24, 2024
Atypical presentations of RECQL4-related syndromesLiron D Grossman, Sarah Baldino, Kristin Zelley, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcomaElizabeth Fox, Christine Busch, Alexander DeBernardo, et al.
International Journal of Pediatric Endocrinology|May 15, 2015
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapyMaya Lodish, Alexandra Gkourogianni, Ethan Bornstein, et al.
Blood Advances|July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairmentCatherine Lai, Diane E Cole, Seth M Steinberg, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2003
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancerPatrick Thompson, Frank Balis, Baruti M Serabe, et al.
Mutation Research|June 2, 2005
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administrationV Koneti Rao, Turid Knutsen, Thomas Ried, et al.
Pageof 2